This cluster of buys is economically trivial and should not be read as a bullish signal. The $653K outlay by two directors is routine portfolio adjustment. Monitor for any pending earnings or pipeline catalyst, but the insider activity itself offers no actionable edge.
ZTS drugs
ZTS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 14 $75.24entry
- T+1 · 6mo ago −2.15%α −0.93% · $73.62
- T+5 · 6mo ago +6.30%α +7.02% · $79.98
- T+20 · 5mo ago +5.76%α +6.61% · $79.57
- T+60 · 3mo ago −0.58%α −3.91% · $74.80
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Zoetis directors made open-market purchases totaling $653K on May 13, 2026, a modest 0.002% of market cap. Director Parent exercised non-cash derivative conversions on May 20 with zero economic outlay. The cluster buys are trivial relative to the $33.4B market cap and do not signal material insider conviction.
Key Financial Metrics
Key Facts
- Two directors (Damelio, Bisaro) purchased 8,700 shares for $653K on May 13
- Director Parent exercised 14,075 derivative shares at $0 on May 20 (non-cash)
- Total cluster dollar value of $653K equals ~0.002% of $33.4B market cap
- 30-day insider activity shows only $886K in total purchases prior to this cluster
- No cash sales occurred in the cluster window
Financial Impact
Open-market buys of $653K are de minimis, far below any materiality threshold for a $33.4B company
Risk Factors
- Insider purchases may simply reflect personal portfolio diversification at a stock beaten down from prior levels
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ZTS-1779396569350 |
Track record
10 reports on ZTS
5 of 5 bullish or bearish reports moved the stock their way by T+1. Best: +38.10% at T+60 after the Feb 27, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $82.11 to $79.40 Now $84.39 −2.78% ▲ +3.30% +3.61% vs SPY
- Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $79.52 to $79.96 Now $84.39 +6.13% ▲ +0.55% +0.22% vs SPY
- Oct 13, 20264w ago 8-K Neutral 2/10 Entry $74.30 to $75.29 Now $84.39 +13.58% ▲ +1.33% +2.41% vs SPY
- Oct 8, 20265w ago 8-K Neutral 2/10 Entry $74.81 to $75.65 Now $84.39 +12.81% ▲ +1.12% +1.18% vs SPY
- Aug 6, 202614w ago 8-K Bearish 7/10 Entry $77.05 to $72.36 Now $84.39 −9.53% ▲ +6.09% +6.70% vs SPY
- May 20, 202625w ago 8-K Neutral 2/10 Entry $79.98 to $81.17 Now $84.39 +5.52% ▲ +1.49% +1.04% vs SPY
- May 13, 202626w ago Insider Cluster Neutral 2/10 Viewing Entry $75.24 to $73.62 Now $84.39 +12.16% ▼ −2.15% −0.93% vs SPY
- May 7, 202627w ago 8-K Bearish 7/10 Entry $87.24 to $82.31 Now $84.39 +3.27% ▲ +5.65% +6.48% vs SPY
- Apr 8, 202631w ago DEFA14A Neutral 2/10 Entry $119.65 to $119.47 Now $84.39 −29.47% ▼ −0.15% −0.72% vs SPY
- Feb 27, 202637w ago Court Ruling Bearish 6/10 Entry $127.51 to $124.52 Now $84.39 +33.82% ▲ +2.35% +1.47% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers